Correction to: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation (Nature Communications, (2019), 10, 1, (448), 10.1038/s41467-018-08271-x)

Jun Yan, Qingnan Zhao, Konrad Gabrusiewicz, Ling Yuan Kong, Xueqing Xia, Jian Wang, Martina Ott, Jingda Xu, R. Eric Davis, Longfei Huo, Ganesh Rao, Shao Cong Sun, Stephanie S. Watowich, Amy B. Heimberger, Shulin Li

Research output: Contribution to journalComment/debatepeer-review

6 Scopus citations

Abstract

The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish (US)
Article number862
JournalNature communications
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General Physics and Astronomy

MD Anderson CCSG core facilities

  • Biostatistics Resource Group

Fingerprint

Dive into the research topics of 'Correction to: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation (Nature Communications, (2019), 10, 1, (448), 10.1038/s41467-018-08271-x)'. Together they form a unique fingerprint.

Cite this